Higher doses of radiotherapy control localized prostate cancer (PCa) more effectively than lower doses 10 years after treatment and reduced the need for follow-up androgen-deprivation therapy, according to investigators. Read the article.
More Intensive Radiation May Be Best for Prostate Cancer Read More »
An observational study from UCLA’s Jonsson Comprehensive Cancer Center has found that prostate cancer patients who undergo robotic-assisted prostate surgery have fewer instances of cancer cells at the edge of their surgical specimen and less need for additional cancer treatments like hormone or radiation therapy than patients who have traditional “open” surgery. Read the article.
UCLA study finds robotic-assisted prostate surgery offers better cancer control Read More »
This is a summary article from the National Cancer Institute. Read the article.
Hormone Therapy for Prostate Cancer Read More »
Here are 2 articles on Gleason 6 Prostate Cancer: Gleason 6 Prostate Cancer: Serious Malignancy or Toothless Lion? – See More and a follow-up: Gleason 6 Cancer Is Still Cancer – See More
Gleason 6 Prostate Cancer: Serious Malignancy or Toothless Lion? Read More »
An Interview with Frank Critz, MD Some may find it surprising that Frank A. Critz, MD—a radiation oncologist who focuses on prostate cancer—generally considers radical prostatectomy to be the go-to treatment for localized disease. But now that he and fellow investigators have completed a 25-year study showing radiation therapy outcomes to be equal to those of radical prostatectomy under the strict surgical definition of prostate cancer control (The Journal of Urology 2013;189[3]: 878-883), Dr. Critz—the founder and medical director of Radiotherapy Clinics of Georgia–Decatur (an affiliate of Vantage Oncology), can comfortably recommend both options to patients. Read the article. (Free
PCa Control Similar with Radiation, Radical Surgery Read More »
Men with intermediate or high-risk localised prostate cancer should be given a combination of radical radiotherapy and androgen deprivation therapy, rather than radical radiotherapy or androgen deprivation therapy alone, recommends newly updated guidance [publications.nice.org.uk] from the National Institute of Health and Care Excellence (NICE), published today. Read the article.
Combine treatment for moderate to high risk prostate cancer Read More »
8th January 2014 – New guidance for the NHS in England on how best to diagnose and treat prostate cancer has been published by the National Institute for Health and Care Excellence (NICE). The guidance aims to ensure that men are given information about the treatment options available, even if they are not available locally, as well as help choosing the best option to suit them. Read more.
New prostate cancer treatment guidelines in UK Read More »
Researchers from Weill Cornell Medical College have shown that the presence of a particular protein in biopsied prostate tissue substantially increases the likelihood that cancer will develop in that organ. The discovery will likely help physicians decide how closely to monitor men potentially at risk for the cancer—among the most confusing and controversial dilemmas in health care. Read the article.
Protein in prostate biopsies signals increased cancer risk Read More »
A new test for prostate cancer could spare thousands of men needless treatment which leaves them with debilitating side effects, researchers claim. The test can accurately pinpoint the less harmful tumours which do not have to be immediately removed by surgery or radiotherapy. Read more: http://www.dailymail.co.uk/health/article-2487483/New-prostate-test-identifies-harmful-tumours-need-removed-immediately-spare-men-needless-surgery.html#ixzz2lIfSTsd7
This is one of Dr. Myers’ regular videos. To view it and related videos, click here.
Avodart + Active Surveillance Read More »